Migaczewski Marcin, Pędziwiatr Michał, Matłok Maciej, Budzyński Andrzej
Second Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland.
Wideochir Inne Tech Maloinwazyjne. 2013 Jun;8(2):139-45. doi: 10.5114/wiitm.2011.32941. Epub 2013 Jan 21.
Barrett's esophagus (BE) is a state in which the distal portion of esophageal mucosa becomes lined with cylindrical epithelium as a result of adaptive remodeling. It is widely accepted that the metaplastic lesions result from chronic irritation with gastric and/or duodenal contents in the course of reflux disease. For many years, research centered on the risk factors of BE and resulting adenocarcinoma. Anti-reflux operations are the only procedures which offer the possibility of treating the cause by restoring the anatomic barrier responsible for guarding against irritating effects of gastroduodenal content on the distal esophagus. Total (i.e. 360°) laparoscopic Nissen fundoplication (LNF) is considered the most effective amongst these procedures. Still, controversies related to the indications for anti-reflux surgery are frequently encountered.
Retrospective analysis of long-term treatment outcomes in patients with BE subjected to laparoscopic Nissen fundoplication.
The group included 42 BE patients, amongst them 30 men and 12 women. Initially, all the patients were treated conservatively for at least 1 year. The subgroup with dysplasia was subjected to preoperative argon plasma coagulation (APC). From 1 year after surgery (laparoscopic Nissen fundoplication), control biopsy specimens were obtained from the gastroesophageal junction of all the patients.
None of the patients showed the development of esophageal adenocarcinoma during the follow-up period. Furthermore, no cases of dysplasia progression or de novo development of dysplasia were observed in the analyzed group. In the initial 12-24 months after surgery, complete regression of metaplasia was documented in 7 (31.8%) patients from group A, and a reduction in the area of Barrett's metaplasia was observed in another 7 patients (31.8%). Throughout the period of this study, persistent planoepithelial re-epithelialization was observed in 14 (70%) group B patients, i.e. in individuals with baseline dysplasia subjected to preoperative argon plasma ablation. In the remaining patients of this group, the developed changes of BE character were less advanced than at baseline.
Our opinion is that laparoscopic Nissen fundoplication, as a result of high effectiveness, represents the method of choice in the treatment of BE in the case of patients who were qualified for surgery.
巴雷特食管(BE)是一种食管黏膜远端部分因适应性重塑而被柱状上皮覆盖的状态。人们普遍认为,化生病变是由反流性疾病过程中胃和/或十二指肠内容物的慢性刺激引起的。多年来,研究主要集中在BE及其所致腺癌的危险因素上。抗反流手术是唯一有可能通过恢复防止胃十二指肠内容物对食管远端产生刺激作用的解剖屏障来治疗病因的手术。全(即360°)腹腔镜nissen胃底折叠术(LNF)被认为是这些手术中最有效的。然而,抗反流手术的适应证相关争议仍屡见不鲜。
对接受腹腔镜nissen胃底折叠术的BE患者的长期治疗结果进行回顾性分析。
该组包括42例BE患者,其中男性30例,女性12例。最初,所有患者均接受了至少1年的保守治疗。发育异常亚组患者术前行氩等离子体凝固(APC)治疗。自手术(腹腔镜nissen胃底折叠术)后1年起,从所有患者的胃食管交界处获取对照活检标本。
随访期间,无一例患者发生食管腺癌。此外,在分析组中未观察到发育异常进展或新发发育异常的病例。术后最初的12 - 24个月内,A组7例(31.8%)患者化生完全消退,另有7例患者(31.8%)巴雷特化生面积减小。在本研究期间,B组14例(70%)患者,即术前接受氩等离子体消融的基线发育异常个体,观察到持续性扁平上皮再上皮化。该组其余患者BE特征的变化程度低于基线水平。
我们认为,腹腔镜nissen胃底折叠术由于疗效显著,对于符合手术条件的BE患者而言是首选治疗方法。